share_log

四環醫藥：環境、社會及管治報告2023

SIHUAN PHARM: ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023

Hong Kong Stock Exchange ·  Apr 26 04:36
Summary by Moomoo AI
四環醫藥控股集團有限公司（四環醫藥）於2024年3月28日批准發佈了其第八份環境、社會及管治報告，全面闡述了公司在2023年度的環境、社會及管治實踐表現。報告涵蓋了2023年1月1日至12月31日的績效，並嚴格遵循香港聯合交易所有限公司證券主板上市規則附錄C2的《環境、社會及管治報告指引》。四環醫藥在報告中強調了其對環境保護的承諾，包括減少廢氣排放、提高能源使用效率、嚴格控制廢水排放和廢棄物管理。公司還著重於員工的健康與安全，提供了全面的職業健康檢查和安全培訓。此外，四環醫藥在供應鏈管理上實施了一系列綠色採購和廉潔採購政策，以確保供應鏈的可持續性和合規性。報告還展示了公司在社會參與方面的努力，包括支持教育發展、鄉村振興以及公益慈善活動。四環醫藥的這份報告展現了其作為負責任企業的形象，並對未來的可持續發展目標作出承諾。
四環醫藥控股集團有限公司（四環醫藥）於2024年3月28日批准發佈了其第八份環境、社會及管治報告，全面闡述了公司在2023年度的環境、社會及管治實踐表現。報告涵蓋了2023年1月1日至12月31日的績效，並嚴格遵循香港聯合交易所有限公司證券主板上市規則附錄C2的《環境、社會及管治報告指引》。四環醫藥在報告中強調了其對環境保護的承諾，包括減少廢氣排放、提高能源使用效率、嚴格控制廢水排放和廢棄物管理。公司還著重於員工的健康與安全，提供了全面的職業健康檢查和安全培訓。此外，四環醫藥在供應鏈管理上實施了一系列綠色採購和廉潔採購政策，以確保供應鏈的可持續性和合規性。報告還展示了公司在社會參與方面的努力，包括支持教育發展、鄉村振興以及公益慈善活動。四環醫藥的這份報告展現了其作為負責任企業的形象，並對未來的可持續發展目標作出承諾。
SIWAN PHARMACEUTICAL HOLDINGS GROUP LIMITED (SIWAN PHARMACEUTICALS) APPROVED ON 28 MARCH 2024 THE RELEASE OF ITS EIGHTH ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT, WHICH FULLY OUTLINES THE COMPANY'S PERFORMANCE OF ENVIRONMENTAL, SOCIAL AND GOVERNANCE PRACTICES IN 2023. The report covers performance from 1 January to 31 December 2023 and strictly complies with the Environmental, Social and Governance Reporting Guidelines in Appendix C2 to the Listing Rules on the Main Board of Hong Kong Stock Exchange Limited. In the report, Quadruple Pharmaceuticals emphasized its commitment to environmental protection, including reducing emissions, improving energy efficiency, strictly controlling wastewater emissions and waste management. The company also focuses on the health and safety of employees, providing comprehensive occupational health checks and safety training. In addition, Quadruple Pharmaceuticals has implemented a range...Show More
SIWAN PHARMACEUTICAL HOLDINGS GROUP LIMITED (SIWAN PHARMACEUTICALS) APPROVED ON 28 MARCH 2024 THE RELEASE OF ITS EIGHTH ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT, WHICH FULLY OUTLINES THE COMPANY'S PERFORMANCE OF ENVIRONMENTAL, SOCIAL AND GOVERNANCE PRACTICES IN 2023. The report covers performance from 1 January to 31 December 2023 and strictly complies with the Environmental, Social and Governance Reporting Guidelines in Appendix C2 to the Listing Rules on the Main Board of Hong Kong Stock Exchange Limited. In the report, Quadruple Pharmaceuticals emphasized its commitment to environmental protection, including reducing emissions, improving energy efficiency, strictly controlling wastewater emissions and waste management. The company also focuses on the health and safety of employees, providing comprehensive occupational health checks and safety training. In addition, Quadruple Pharmaceuticals has implemented a range of green procurement and clean procurement policies across its supply chain management to ensure supply chain sustainability and compliance. The report also highlights the company's efforts in social engagement, including support for educational development, rural revitalization, and charitable causes. This report by Quadruple Pharmaceuticals demonstrates its image as a responsible company and a commitment to its sustainability goals for the future.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more